Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Fall;19(4):51-58.
doi: 10.22037/ijpr.2020.112442.13760.

Histone Deacetylase Inhibitory and Cytotoxic Activities of the Constituents from the Roots of Sophora Pachycarpa

Affiliations

Histone Deacetylase Inhibitory and Cytotoxic Activities of the Constituents from the Roots of Sophora Pachycarpa

Saba Soltani et al. Iran J Pharm Res. 2020 Fall.

Abstract

Four prenylated flavonoids, including isosophoranone, sophoraflavanone G, alopecurone J, alopecurone P, and a resveratrol derivative HPD (2-(4-hydroxyphenyl)-2,3-dihydrobenzo[b] furan-3,4,6-triol), were isolated from the roots of Sophora pachycarpa. The cytotoxic activity of obtained compounds was evaluated against A2780, A549, HeLa, and HCT116 human cancer cell lines. We also evaluated their histone deacetylase (HDAC) inhibitory activities. Of all compounds tested, alopecurone J was the most active with IC50 values in the range of 9.97-30.91 μM against four cancer cell lines with potent pan-HDAC inhibitory activity (IC50 = 0.08-3.85 μM). Molecular docking experiments of these compounds with HDAC8 displayed potential selective HDAC inhibitory. Molecular docking data showed consistent results in the in-vitro experiments with high selectivity towards HDAC8. The Resveratrol group plays an essential role in HDAC inhibition.

Keywords: Cytotoxicity; Histone deacetylase inhibitors; Molecular docking; Sophora pachycarpa; prenylated flavonoids.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures of isosophoranone (1), sophoraflavanone G (2), 2-(4-hydroxyphenyl)-2,3-dihydrobenzo[b]furan-3,4,6-triol (3), alopecurone J (4) and alopecurone P (5).
Figure 2
Figure 2
Docking model structure of compound 4 into the active site of HDAC8 protein binding pocket
Figure 3
Figure 3
Binding model of compound 4 into active pocket of HDAC8

Similar articles

Cited by

References

    1. Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. . 2006;5:769–84. - PubMed
    1. Kumboonma P, Senawong T, Saenglee S, Yenjai C, Phaosiri C. New histone deacetylase inhibitors from the twigs of Melanorrhoea usitata. Med. Chem. Res. . 2018;27:2004–15.
    1. Zhou Zh, Yang J, Kong AN. Phytochemicals in traditional Chinese herbal medicine: Cancer prevention and epigenetics mechanisms. Curr. Pharmacol. Rep. . 2017;3:77–91.
    1. Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N, Qian X, Mills E, Berghs SC, Carey N. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem. J. . 2008;409:581–9. - PubMed
    1. Brien GL, Valerio DG, Armstrong SA. Exploiting the epigenome to control cancer-promoting gene-expression programs. Cancer Cell . 2016;29:464–76. - PMC - PubMed

LinkOut - more resources